IGC Pharma Executives Increase Ownership With $1.15 Million Share Purchase

Jul 7, 2026

IGC Pharma (NYSE American: IGC) announced that CEO Ram Mukunda and Principal Financial Officer Claudia Grimaldi have increased their ownership in the company by purchasing an aggregate of nearly 4.3 million shares of common stock directly from IGC at $0.27 per share. Following the transaction, the two executives collectively own approximately 10% of the company’s outstanding common stock.

The share purchases were completed through the cancellation of approximately $1.15 million in amounts previously owed by the company, including more than $552,000 in personal cash advances made to IGC by the executives. The transaction was completed entirely in restricted common stock and reflects increased insider ownership as IGC continues advancing its Alzheimer’s disease therapeutics and AI-enabled healthcare technologies.

#IGCPharma
#IGC
#Alzheimers
#Biotech
#Healthcare
#ArtificialIntelligence
#InsiderBuying
#StockMarket
#CorporateNews
#ClinicalTrials
#HealthcareInnovation
#Biotechnology
#NYSEAmerican
#JaneKing
#NewsOut